These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1729321)

  • 1. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms.
    Callans DJ; Marchlinski FE
    J Am Coll Cardiol; 1992 Jan; 19(1):111-7. PubMed ID: 1729321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procainamide in the induction and perpetuation of ventricular tachycardia in man.
    Kang PS; Gomes JA; El-Sherif N
    Pacing Clin Electrophysiol; 1982 May; 5(3):311-22. PubMed ID: 6179048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
    Grimm W; Cho JG; Marchlinski FE
    J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of procainamide on the signal-averaged electrocardiogram in relation to the results of programmed ventricular stimulation in patients with sustained monomorphic ventricular tachycardia.
    Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ
    J Am Coll Cardiol; 1993 May; 21(6):1428-39. PubMed ID: 8473652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide.
    Buxton AE; Josephson ME; Marchlinski FE; Miller JM
    J Am Coll Cardiol; 1993 Jan; 21(1):90-8. PubMed ID: 8417082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of procainamide on the inducibility of ventricular tachycardia using programmed stimulation].
    Lukl J; Heinc P; Cernosek B
    Vnitr Lek; 1989 Nov; 35(11):1049-56. PubMed ID: 2623834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
    Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME
    Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction.
    Karagueuzian HS; Ohta M; Drury JK; Fishbein MC; Meerbaum S; Corday E; Mandel WJ; Peter T
    J Am Coll Cardiol; 1986 Mar; 7(3):551-63. PubMed ID: 3950235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential effect of procainamide on the reentrant circuit of ventricular tachycardia.
    Kay GN; Epstein AE; Plumb VJ
    J Am Coll Cardiol; 1989 Aug; 14(2):382-90. PubMed ID: 2754127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group.
    Singh BN; Kehoe R; Woosley RL; Scheinman M; Quart B
    Am Heart J; 1995 Jan; 129(1):87-97. PubMed ID: 7817931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.
    Marchlinski FE; Buxton AE; Vassallo JA; Waxman HL; Cassidy DM; Doherty JU; Josephson ME
    J Am Coll Cardiol; 1984 Dec; 4(6):1247-54. PubMed ID: 6209319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination of ventricular tachycardia: role of tachycardia cycle length.
    Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME
    Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide.
    Widerhorn J; Sager PT; Rahimtoola SH; Bhandari AK
    Pacing Clin Electrophysiol; 1991 Mar; 14(3):420-6. PubMed ID: 1708872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
    Ortiz M; Martín A; Arribas F; Coll-Vinent B; Del Arco C; Peinado R; Almendral J;
    Eur Heart J; 2017 May; 38(17):1329-1335. PubMed ID: 27354046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
    Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.